|

Tumor-Lymph Node Mapping

RECRUITINGSponsored by University of Rochester
Actively Recruiting
SponsorUniversity of Rochester
Started2026-04-13
Est. completion2028-07-30
Eligibility
Age1 Month – 17 Years
Healthy vol.Accepted
Locations1 site

Summary

The purpose of this study is to assess the feasibility and safety of ICG-guided intraoperative lymphography for detecting sentinel lymph nodes (SLN) in pediatric patients with solid tumors who require retroperitoneal lymph node dissection/sampling. This trial is a single-site cross-sectional study. The injection of ICG directly into lymphatics draining the primary tumor will take place at the time of operation after the patient is under anesthesia.

Eligibility

Age: 1 Month – 17 YearsHealthy volunteers accepted
Inclusion Criteria:

* Any pediatric patient (under the age of 18 years) being treated at the University of Rochester Medical Center, Department of Surgery.
* Diagnosed with pediatric solid tumor
* Scheduled to undergo lymph node sampling as part of their clinical management.

Exclusion Criteria:

* Subjects with a history of iodide allergies.
* Inability or unwillingness of research participant or parent/legal guardian to give written informed consent.
* Currently pregnant.
* Infants under 650 grams.
* Patients with extensive prior surgery at the primary site or nodal basin expected to affect the lymphatic drainage.

Conditions5

CancerGerm Cell TumorPediatric Solid TumorsRhabdomyosarcomaSarcoma

Locations1 site

University of Rochester Medical Center
Rochester, New York, 14642

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.